SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-042020
Filing Date
2018-11-01
Accepted
2018-11-01 06:46:25
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 584563
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 13179
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 13453
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5665
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5839
  Complete submission text file 0001140361-18-042020.txt   3569425

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT edge-20180930.xml EX-101.INS 542576
7 XBRL TAXONOMY EXTENSION SCHEMA edge-20180930.xsd EX-101.SCH 36188
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20180930_cal.xml EX-101.CAL 36469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20180930_def.xml EX-101.DEF 150373
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20180930_lab.xml EX-101.LAB 560577
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20180930_pre.xml EX-101.PRE 290070
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 181151921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences